President-Ceo
CurrentBone Solutions, Inc. ("BSI") is an orthobiologics technology company that has developed a patent-protected platform of adhesives whose initial indication is an FDA-approved novel Bone Void Filler (BVF) for grafting of bony voids or defects that are not intrinsic to the stability of the bony structure. The company’s first proprietary product, OsteoCrete™, is biocompatible magnesium-based BVF that is injectable, moldable and highly resorbable